Colorado Institute of Public Policy, author2017-12-142017-12-142004-10https://hdl.handle.net/10217/185447October 2004.Includes bibliographical references.Making informed decisions about bio-pharming in Colorado comes down to case-by-case analysis of economic-development benefits and health, environmental and market-related risks. Raising genetically engineered crops for pharmaceuticals and industrial compounds often is called "molecular farming" or "bio-pharming." Scientists have envisioned the technology for 20 years, but application is in its infancy. In summer 2004, the first bio-pharm crop was planted in Colorado. The experimental research crop of 2,000 engineered corn plants puts Colorado at a policy crossroads. This paper addresses these important questions by providing relevant scientific information and frameworks to guide decision-making.born digitalreportsengCopyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see https://libguides.colostate.edu/copyright.Plant biotechnology -- ColoradoCrops -- Genetic engineering -- ColoradoPharmaceutical biotechnology -- ColoradoText